Advanced Prostate Cancer Drug May Help during Earlier Stage

<p>WEDNESDAY, May 16 (HealthDay News) A drug authorized to treat
advanced prostate cancer appears to assistance organisation who have localized high-risk
prostate cancer if given before surgery.
Adding Zytiga (abiraterone) to required hormonal treatments
eliminated or scarcely separated a prostate cancer in one-third of men
with this often-lethal form, according to new examine to be presented at
next months annual assembly of a American Society of Clinical Oncology
(ASCO) in Chicago.
This is one of a initial if not a initial examine to uncover that you
can make prostate cancer in a prostate gland itself disappear in a
reproducible series of patients, ASCO central Dr. Nicholas Vogelzang
said during a Wednesday press conference.
Commenting on a findings, Dr. Jay Brooks, authority of
hematology/oncology during Ochsner Health System in Baton Rouge, said, This
is exciting. Its a novel approach to discharge cancer before surgery.
However, Brooks, who was not concerned in a study...